Your session is about to expire
← Back to Search
CV0501 (6 μg) for COVID-19
Study Summary
This trial is testing an investigational vaccine to see if it can prevent COVID-19, caused by the SARS-CoV-2 virus.
- COVID-19
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are medical professionals currently enrolling participants for this trial?
"Confirming the information available on clinicaltrials.gov, this medical experiment is actively recruiting participants and was posted on August 12th 2022 with a recent update occurring November 22nd 2022."
How many medical establishments are currently hosting this clinical research?
"This trial is occurring at Meridian Clinical Research (Savannah Georgia) in Savannah, GA, Sundance Clinical Research in Saint Louis, MO, and Research Centers of America - CenExcel in Hollywood, FL with additional sites scattered across the United States."
Has the 6 μg dosage of CV0501 been approved by the FDA?
"A score of 1 has been assigned to the safety of CV0501 (6 μg) due to it being in the preliminary Phase 1 trial stage. There is only limited clinical evidence that confirms its efficacy and safety profile."
Share this study with friends
Copy Link
Messenger